Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,376–1,400 of 7,816 matching trials · page 56 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients NCT05756270 pCASL Runs in: Italy · 1 site |
NA other |
COMPLETED | 150 | University of Milano Bicocca OTHER |
2026-03-24 |
|
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision NCT06313853 COACH-Cog Runs in: United States · 1 site |
NA other |
RECRUITING | 300 | University of Rochester OTHER |
2026-03-24 |
|
Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression NCT06898424 Ketoflex 12/3 Diet Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 60 | Prof. Lutfu Hanoglu, MD OTHER |
2026-03-24 |
|
Brain NAD in Alzheimer's Disease NCT07127510 Runs in: United States · 1 site |
NA other |
RECRUITING | 20 | Florida Atlantic University OTHER |
2026-03-24 |
|
A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease NCT07489599 QLH2405; QLH2405; Placebo; QLH2405; Placebo; QLH2405; Placebo; QLH2... |
PHASE1 other |
NOT_YET_RECRUITING | 68 | Qilu Pharmaceutical Co., Ltd. INDUSTRY |
2026-03-24 |
|
Context- and Terrain-aware Gait Analysis NCT07491588 All-terrain Gait Analysis System |
NA other |
WITHDRAWN | 0 | University of Leeds OTHER |
2026-03-24 |
|
China Cognition and Aging Study NCT03653156 Runs in: China · 65 sites |
NA other |
RECRUITING | 100,000 | Capital Medical University OTHER |
2026-03-23 |
|
The Chinese Familial Alzheimer's Network NCT03657732 Runs in: China · 65 sites |
NA other |
RECRUITING | 40,000 | Capital Medical University OTHER |
2026-03-23 |
|
Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia NCT03804229 Butylphthalide soft capsule; Placebo soft capsule Runs in: China · 1 site |
PHASE3 other |
ACTIVE_NOT_RECRUITING | 707 | Capital Medical University OTHER |
2026-03-23 |
|
Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia NCT04042532 Theta-burst stimulation (TBS) Runs in: Taiwan · 1 site |
NA other |
ENROLLING_BY_INVITATION | 70 | Chang Gung Memorial Hospital OTHER |
2026-03-23 |
|
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease NCT04575337 Runs in: China · 1 site |
NA other |
RECRUITING | 6,000 | Capital Medical University OTHER |
2026-03-23 |
|
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis NCT04850053 Runs in: China · 1 site |
NA other |
RECRUITING | 1,500 | Capital Medical University OTHER |
2026-03-23 |
|
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease NCT05020106 Runs in: China · 1 site |
NA other |
RECRUITING | 3,200 | Capital Medical University OTHER |
2026-03-23 |
|
Cognitive Effects of Theta-burst Stimulation (TBS) in Suspected Non-Alzheimer Disease Pathophysiology (SNAP) NCT05440110 active and active TBS; sham and active TBS Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 17 | Chang Gung Memorial Hospital OTHER |
2026-03-23 |
|
Cognitive Effects and Potential Mechanisms of TBS in Subjects With MCI NCT05448768 TBS for Amyloid-positive MCI; TBS for Amyloid-negative MCI Runs in: Taiwan · 1 site |
NA other |
ENROLLING_BY_INVITATION | 80 | Chang Gung Memorial Hospital OTHER |
2026-03-23 |
|
Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure NCT05601817 Vita; Com; Vita+Com Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 172 | Indiana University OTHER |
2026-03-23 |
|
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial NCT05860127 Referral for Cognitive Stimulation Therapy; No change to Standard of Care Runs in: United States · 2 sites |
NA other |
COMPLETED | 133 | University of Massachusetts, Amherst OTHER |
2026-03-23 |
|
The Ketogenic Diet in the Treatment of Alzheimer's Disease NCT06681948 Ketogenic diet; placebo Runs in: China · 1 site |
NA other |
COMPLETED | 32 | Capital Medical University OTHER |
2026-03-23 |
|
Concurrent Trials on Nature-Based Therapy for Inpatients in Dementia and Rehabilitation Medicine Wards NCT07059390 Nature Immersion Therapy Runs in: Singapore · 1 site |
NA other |
NOT_YET_RECRUITING | 1,600 | Changi General Hospital OTHER |
2026-03-23 |
|
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study NCT00317616 Runs in: United States · 1 site |
NA other |
RECRUITING | 500 | University of Miami OTHER |
2026-03-20 |
|
A Study to Evaluate Temporary Blood Brain Barrier Disruption in Patients With Parkinson's Disease Dementia NCT03608553 MR Guided Focused Ultrasound Runs in: Spain · 1 site |
NA other |
COMPLETED | 20 | InSightec INDUSTRY |
2026-03-20 |
|
TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory NCT04294888 repetitive transcranial magnetic stimulation (rTMS) Runs in: United States · 1 site |
NA other |
TERMINATED | 4 | Massachusetts General Hospital OTHER |
2026-03-20 |
|
Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA NCT04627662 Tele-STELLA Runs in: United States · 1 site |
NA other |
COMPLETED | 375 | Oregon Health and Science University OTHER |
2026-03-20 |
|
The Dose Finding Study of DAOIB Added to tDCS for AD NCT05006781 DAOIB Runs in: Taiwan · 1 site |
PHASE2 other |
SUSPENDED | 140 | Chang Gung Memorial Hospital OTHER |
2026-03-20 |
|
NMDA Enhancement Combined With Omega-3 for Early Dementia NCT05181189 DAOIB+Omega-3; DAOIB+Placebo Runs in: Taiwan · 1 site |
PHASE2 symptomatic-cholinergic |
NOT_YET_RECRUITING | 140 | Chang Gung Memorial Hospital OTHER |
2026-03-20 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial